Status:
UNKNOWN
Evaluation of High Dose Methotrexate Toxicity
Lead Sponsor:
Sohag University
Conditions:
Methotrexate Toxicity
Eligibility:
All Genders
1-18 years
Brief Summary
This study aims to: 1. Evaluation of high dose methotrexate related toxicities among children admitted to Sohag Oncology Centre. 2. Role of methotrexate blood level in prediction of high dose methotr...
Detailed Description
It is a prospective observational study will be carried out on children receiving high dose methotrexate in Sohag Oncology Centre with one-year observation starting from January 2024. All children re...
Eligibility Criteria
Inclusion
- Children admitted to Sohag Oncology Centre, age from 1 to 18 years
- receive high dose methotrexate therapy equal to or more than 1 gm/m2 surface area.
Exclusion
- WBCs less than 1000 / microliter
- Platelet count less than 50000 / microliter
- Renal affection
- Hepatic affection
- Respiratory affection
- Diabetes mellitus
- Cardiovascular disease
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06123403
Start Date
January 1 2024
End Date
June 1 2025
Last Update
November 8 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.